188 related articles for article (PubMed ID: 30782859)
1.
Nava S; White AC; Castellanos-González A
Infect Immun; 2019 Mar; 87(5):. PubMed ID: 30782859
[TBL] [Abstract][Full Text] [Related]
2. Cryptosporidium parvum cyclic GMP-dependent protein kinase (PKG): An essential mediator of merozoite egress.
Nava S; Sadiqova A; Castellanos-Gonzalez A; White AC
Mol Biochem Parasitol; 2020 May; 237():111277. PubMed ID: 32348840
[TBL] [Abstract][Full Text] [Related]
3. Role of CpSUB1, a subtilisin-like protease, in Cryptosporidium parvum infection in vitro.
Wanyiri JW; Techasintana P; O'Connor RM; Blackman MJ; Kim K; Ward HD
Eukaryot Cell; 2009 Apr; 8(4):470-7. PubMed ID: 19168760
[TBL] [Abstract][Full Text] [Related]
4. Prodomain-driven enzyme dimerization: a pH-dependent autoinhibition mechanism that controls
Martinez M; Bouillon A; Brûlé S; Raynal B; Haouz A; Alzari PM; Barale J-C
mBio; 2024 Mar; 15(3):e0019824. PubMed ID: 38386597
[TBL] [Abstract][Full Text] [Related]
5. A key role for Plasmodium subtilisin-like SUB1 protease in egress of malaria parasites from host hepatocytes.
Tawk L; Lacroix C; Gueirard P; Kent R; Gorgette O; Thiberge S; Mercereau-Puijalon O; Ménard R; Barale JC
J Biol Chem; 2013 Nov; 288(46):33336-46. PubMed ID: 24089525
[TBL] [Abstract][Full Text] [Related]
6. Activation of the
Mukherjee S; Nasamu AS; Rubiano KC; Goldberg DE
mBio; 2023 Apr; 14(2):e0067323. PubMed ID: 37036362
[TBL] [Abstract][Full Text] [Related]
7. Labeling surface epitopes to identify Cryptosporidium life stages using a scanning electron microscopy-based immunogold approach.
Edwards H; Thompson RC; Koh WH; Clode PL
Mol Cell Probes; 2012 Feb; 26(1):21-8. PubMed ID: 22100878
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium subtilisin-like protease 1 (SUB1): insights into the active-site structure, specificity and function of a pan-malaria drug target.
Withers-Martinez C; Suarez C; Fulle S; Kher S; Penzo M; Ebejer JP; Koussis K; Hackett F; Jirgensons A; Finn P; Blackman MJ
Int J Parasitol; 2012 May; 42(6):597-612. PubMed ID: 22543039
[TBL] [Abstract][Full Text] [Related]
9. Subtilisin-like Serine Protease 1 (SUB1) as an Emerging Antimalarial Drug Target: Current Achievements in Inhibitor Discovery.
Lidumniece E; Withers-Martinez C; Hackett F; Blackman MJ; Jirgensons A
J Med Chem; 2022 Oct; 65(19):12535-12545. PubMed ID: 36137276
[TBL] [Abstract][Full Text] [Related]
10. A malaria parasite subtilisin propeptide-like protein is a potent inhibitor of the egress protease SUB1.
Tarr SJ; Withers-Martinez C; Flynn HR; Snijders AP; Masino L; Koussis K; Conway DJ; Blackman MJ
Biochem J; 2020 Jan; 477(2):525-540. PubMed ID: 31942933
[TBL] [Abstract][Full Text] [Related]
11. Systematic gene silencing identified Cryptosporidium nucleoside diphosphate kinase and other molecules as targets for suppression of parasite proliferation in human intestinal cells.
Castellanos-Gonzalez A; Martinez-Traverso G; Fishbeck K; Nava S; White AC
Sci Rep; 2019 Aug; 9(1):12153. PubMed ID: 31434931
[TBL] [Abstract][Full Text] [Related]
12. Cryptosporidium infections: molecular advances.
Lendner M; Daugschies A
Parasitology; 2014 Sep; 141(11):1511-32. PubMed ID: 24679517
[TBL] [Abstract][Full Text] [Related]
13. Activation of the
Mukherjee S; Nasamu AS; Rubiano K; Goldberg DE
bioRxiv; 2023 Jan; ():. PubMed ID: 36712005
[TBL] [Abstract][Full Text] [Related]
14. Peptidic boronic acids are potent cell-permeable inhibitors of the malaria parasite egress serine protease SUB1.
Lidumniece E; Withers-Martinez C; Hackett F; Collins CR; Perrin AJ; Koussis K; Bisson C; Blackman MJ; Jirgensons A
Proc Natl Acad Sci U S A; 2021 May; 118(20):. PubMed ID: 33975947
[TBL] [Abstract][Full Text] [Related]
15. The malaria parasite egress protease SUB1 is a calcium-dependent redox switch subtilisin.
Withers-Martinez C; Strath M; Hackett F; Haire LF; Howell SA; Walker PA; Christodoulou E; Dodson GG; Blackman MJ
Nat Commun; 2014 May; 5():3726. PubMed ID: 24785947
[TBL] [Abstract][Full Text] [Related]
16. Infectivity of Cryptosporidium parvum oocysts following cryopreservation.
Kim HC; Healey MC
J Parasitol; 2001 Oct; 87(5):1191-4. PubMed ID: 11695396
[TBL] [Abstract][Full Text] [Related]
17. Protective monoclonal antibody defines a circumsporozoite-like glycoprotein exoantigen of Cryptosporidium parvum sporozoites and merozoites.
Riggs MW; Stone AL; Yount PA; Langer RC; Arrowood MJ; Bentley DL
J Immunol; 1997 Feb; 158(4):1787-95. PubMed ID: 9029117
[TBL] [Abstract][Full Text] [Related]
18. 3D structures of the Plasmodium vivax subtilisin-like drug target SUB1 reveal conformational changes to accommodate a substrate-derived α-ketoamide inhibitor.
Martinez M; Batista FA; Maurel M; Bouillon A; Ortega Varga L; Wehenkel AM; Le Chevalier-Sontag L; Blondel A; Haouz A; Hernandez JF; Alzari PM; Barale JC
Acta Crystallogr D Struct Biol; 2023 Aug; 79(Pt 8):721-734. PubMed ID: 37428845
[TBL] [Abstract][Full Text] [Related]
19. Cryptosporidium parvum Elongation Factor 1α Participates in the Formation of Base Structure at the Infection Site During Invasion.
Yu X; Guo F; Mouneimne RB; Zhu G
J Infect Dis; 2020 May; 221(11):1816-1825. PubMed ID: 31872225
[TBL] [Abstract][Full Text] [Related]
20. The Cryptosporidium signaling kinase CDPK5 plays an important role in male gametogenesis and parasite virulence.
Nava MG; Szewczyk J; Arrington JV; Alam T; Vinayak S
Cell Rep; 2024 Jun; 43(6):114263. PubMed ID: 38814783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
